Search Press releases Keywords From To 29 May 2017 Transparency notification Read More 23 May 2017 Transparency notification Read More 23 May 2017 Transparency notifications BlackRock, Inc. Read More 21 May 2017 UCB and Amgen announce top-line phase 3 data from active-comparator study of Evenity™ (romosozumab) in postmenopausal women with osteoporosis Read More 17 May 2017 Transparency notification Read More 27 Apr 2017 UCB's General Meeting of Shareholders Read More Pagination First page Previous page Previous … Page 78 Page 79 Page 80 Page 81 Current page 82 Page 83 Page 84 Page 85 Page 86 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
